Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 7Breast Neoplasms 4Multiple Myeloma 2Stomach Neoplasms 1Sarcoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Ovarian Cancer 1

Interventions

Saline Solution 2Bevacizumab 2senaparib 1olaparib 1niraparib 1liposomal doxorubicin 1Tranexamic Acid 1Ropivacaine 1Neoadjuvant Therapy 1Hyperthermic Intraperitoneal Chemotherapy 1Carboplatin 1Antineoplastic Agents 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Ovarian Cancer × 1-dodecylpyridoxal × Clear all
NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed
32 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡